Ben van den Borne

1.1k total citations
28 papers, 697 citations indexed

About

Ben van den Borne is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ben van den Borne has authored 28 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ben van den Borne's work include Lung Cancer Treatments and Mutations (9 papers), Cancer survivorship and care (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Ben van den Borne is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer survivorship and care (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Ben van den Borne collaborates with scholars based in Netherlands, United States and United Kingdom. Ben van den Borne's co-authors include Johan Nuyts, Sandra Silberman, Marc Martens, J. Goeminne, A. van Oosterom, Raf Sciot, Herlinde Dumez, Patrick Dupont, Pascale Colé and Sigrid Stroobants and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and British Journal of Cancer.

In The Last Decade

Ben van den Borne

28 papers receiving 676 citations

Peers

Ben van den Borne

PRM

ONCOL

RNMI

GASTR

Nikolaos Charalampakis Greece

Hanneke W. M. van Laarhoven Netherlands

M. Gauthier France

Hye Sook Han South Korea

Irina M. Cazacu Romania

Wanqing Iris Zhi United States

Yun Hee Lee South Korea

Jae Ill Zo South Korea

Ozan Yazıcı Türkiye

Nikolaos Charalampakis Greece

Ben van den Borne

305 ×0.9

PRM

511 ×2.3

ONCOL

83 ×0.5

RNMI

55 ×0.4

GASTR

163 ×1.9

Citations per year, relative to Ben van den Borne Ben van den Borne (= 1×) peers Nikolaos Charalampakis

Countries citing papers authored by Ben van den Borne

Since Specialization

Citations

This map shows the geographic impact of Ben van den Borne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben van den Borne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben van den Borne more than expected).

Fields of papers citing papers by Ben van den Borne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben van den Borne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben van den Borne. The network helps show where Ben van den Borne may publish in the future.

Co-authorship network of co-authors of Ben van den Borne

This figure shows the co-authorship network connecting the top 25 collaborators of Ben van den Borne. A scholar is included among the top collaborators of Ben van den Borne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben van den Borne. Ben van den Borne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fransen, Heidi P., Natasja Raijmakers, Ben van den Borne, et al.. (2023). Trajectories of emotional functioning and experienced care of relatives in the last year of life of patients with advanced cancer: A longitudinal analysis of the eQuiPe study. Psycho-Oncology. 32(12). 1858–1866. 2 indexed citations

Eussen, Simone J. P. M., M.H.J. van den Beuken-van Everdingen, Hanneke W.M. van Laarhoven, et al.. (2023). Are gastrointestinal problems, nutritional care, and nutritional care needs associated with quality of life in patients with advanced cancer? Results of the observational eQuiPe study. Supportive Care in Cancer. 31(3). 189–189. 1 indexed citations

Borne, Ben van den, Huub Belderbos, Gerben Stege, et al.. (2022). Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer. Translational Oncology. 27. 101589–101589. 15 indexed citations

Hendriks, Lizza, Simon Keek, Avishek Chatterjee, et al.. (2022). 127P Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?. Annals of Oncology. 33. S91–S91. 1 indexed citations

Roij, Janneke van, Natasja Raijmakers, M.H.J. van den Beuken-van Everdingen, et al.. (2022). Quality of life and quality of care as experienced by patients with advanced cancer and their relatives: A multicentre observational cohort study (eQuiPe). European Journal of Cancer. 165. 125–135. 25 indexed citations

Brusse‐Keizer, Marjolein, Hugo Schouwink, Frans H. de Jongh, et al.. (2022). Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose. CHEST Journal. 163(3). 697–706. 44 indexed citations

Schouwink, Hugo, et al.. (2022). Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study.. 2183–2183. 2 indexed citations

Borne, Ben van den, et al.. (2021). Therapy Monitoring of EGFR-Positive Non–Small-Cell Lung Cancer Patients Using ddPCR Multiplex Assays. Journal of Molecular Diagnostics. 23(4). 495–505. 22 indexed citations

Fransen, Heidi P., Ben van den Borne, Mathijs P. Hendriks, et al.. (2021). Bereaved relatives’ quality of life before and during the COVID-19 pandemic: Results of the prospective, multicenter, observational eQuiPe study. Palliative Medicine. 35(8). 1502–1507. 6 indexed citations

10.

Borne, Ben van den, et al.. (2021). Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients. Cancer Treatment and Research Communications. 29. 100449–100449. 5 indexed citations

11.

Borne, Ben van den, Huub Belderbos, Gerben Stege, et al.. (2021). Circulating biomarkers for monitoring therapy response and detection of disease progression in lung cancer patients. Cancer Treatment and Research Communications. 28. 100410–100410. 28 indexed citations

12.

Groen, Harry J.M., Erik H.F.M. van der Heijden, Theo J. Klinkenberg, et al.. (2019). Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study. British Journal of Cancer. 121(5). 372–377. 10 indexed citations

13.

Koornstra, Rutger H.T., et al.. (2014). Management of fatigue in patients with cancer – A practical overview. Cancer Treatment Reviews. 40(6). 791–799. 80 indexed citations

14.

Mellema, Wouter W., Lizza Hendriks, Anthonie J. van der Wekken, et al.. (2014). Retrospective analysis of type of KRAS mutation (mut) and response to first-line platinum-based chemotherapy (PC) in non-small cell lung cancer (NSCLC) patients (pts).. Journal of Clinical Oncology. 32(15_suppl). 8061–8061. 1 indexed citations

15.

Dingemans, Anne‐Marie C., Harry J.M. Groen, Jos A. Stigt, et al.. (2014). A randomized phase II study of paclitaxel-carboplatin-bevacizumab (PCB) with or without nitroglycerin patches (NTG) in patients (pts) with stage IV nonsquamous non-small cell lung cancer (NSCLC): Nvalt 12 (NCT01171170).. Journal of Clinical Oncology. 32(15_suppl). 8089–8089. 2 indexed citations

16.

Anderson, Helén, H. Riska, Serena Knowles, et al.. (2005). Palliative chemotherapy of non-small cell lung cancer (NSCLC): Baseline data analysis of the ACTION observational study in 5 European countries. Journal of Clinical Oncology. 23(16_suppl). 7216–7216. 1 indexed citations

17.

Stroobants, Sigrid, J. Goeminne, Saša Dimitrijević, et al.. (2003). 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®). European Journal of Cancer. 39(14). 2012–2020. 373 indexed citations

18.

Stroobants, Sigrid, J. Goeminne, Marc Martens, et al.. (2001). Early evaluation of tumour response to STI 571 with FDG-PET in patients with soft tissue sarcomas (STS). European Journal of Cancer. 37. S33–S34. 1 indexed citations

19.

Boer, Maarten F. de, Ben van den Borne, J.F.A. Pruyn, et al.. (2000). Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma Results of a 6-year longitudinal study. International Journal of Oral and Maxillofacial Surgery. 29(3). 232–234. 4 indexed citations

20.

Borne, Ben van den. (1999). Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss. British journal of rheumatology. 38(3). 254–259. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact